Search results
Results from the WOW.Com Content Network
Anemia in pregnancy is a decrease in the total red blood cells (RBCs) or hemoglobin in the blood during pregnancy. Anemia is an extremely common condition in pregnancy world-wide, conferring a number of health risks to mother and child. [ 2 ]
Iron deficiency in pregnancy appears to cause long-term and irreversible cognitive problems in the baby. [43] Iron deficiency affects maternal well-being by increasing risks for infections and complications during pregnancy. [44] Some of these complications include pre-eclampsia, bleeding problems, and perinatal infections. [44]
Anemia prevalences during pregnancy differed from 18% in developed countries to 75% in South Asia; culminating to a global rate of 38% of pregnancies worldwide. [ 1 ] [ 5 ] [ 32 ] Treatment varies due to the severity of the anaemia, and can be used by increasing iron containing foods, oral iron tablets or by the use of parenteral iron .
Diseases/conditions that cause red blood cells to rupture, such as a reaction to severe infection/sepsis and certain immune disorders.Certain genetic conditions causing the red blood cells to be ...
Folate deficiency anemia during pregnancy may give rise to the birth of low weight birth premature infants and infants with neural tube defects. [6] Not consuming enough folate can lead to folate deficiency within a few months. [1] Otherwise, causes may include increased needs as with pregnancy, and in those with shortened red blood cell ...
Anemia or anaemia (British English) is a blood disorder in which the blood has a reduced ability to carry oxygen.This can be due to a lower than normal number of red blood cells, a reduction in the amount of hemoglobin available for oxygen transport, or abnormalities in hemoglobin that impair its function.
Although doctors frequently screen for anemia — where a person has too few red blood cells due to low levels of iron — in routine blood tests, people can have enough red blood cells but still ...
During pregnancy, folate deficiency can cause megaloblastic anemia in the mother and poses a significant neurological developmental risk for the fetus. Upon initiation of maternal folate supplementation to prevent fetal abnormalities, reticulocytosis is expected after 3–4 days of treatment. [9]